The molecular portraits of breast tumors are conserved across microarray platformsZhiyuan Hu, Charles M. Perou, Cheng Fan et al.|BMC Genomics|2006Cited by 1.5k
Letrozole Is More Effective Neoadjuvant Endocrine Therapy Than Tamoxifen for ErbB-1– and/or ErbB-2–Positive, Estrogen Receptor–Positive Primary Breast Cancer: Evidence From a Phase III Randomized TrialMatthew J. Ellis, M. Borgs|Journal of Clinical Oncology|2001Cited by 1.1k
Whole-genome analysis informs breast cancer response to aromatase inhibitionMatthew J. Ellis, Mark A. Watson, Li Ding et al.|Nature|2012Cited by 1k
Proteogenomic Analysis of Human Colon Cancer Reveals New Therapeutic OpportunitiesSuhas Vasaikar, Jeffrey R. Whiteaker, Chen Huang et al.|Cell|2019Cited by 849
A Comparison of PAM50 Intrinsic Subtyping with Immunohistochemistry and Clinical Prognostic Factors in Tamoxifen-Treated Estrogen Receptor–Positive Breast CancerTorsten O. Nielsen, Matthew J. Ellis|Clinical Cancer Research|2010Cited by 823